News
Percutaneous Hepatic Perfusion Boosts Melanoma Response
Major Finding: A percutaneous method for targeting melphalan to treat liver metastases while filtering it out of patients' blood before it reached...
About 2,000 cases of ocular melanoma are diagnosed annually in the United States and about 50% metastasize, most often to the liver, according to Delcath. In Europe and Australia, the company markets the device for a broad range of liver metastases, not just those caused by ocular melanoma, according to the company.